Increased cyclooxygenase-2 (cox-2) expression and activity in a murine model of metastatic breast cancer

International Journal of Cancer

Volumn 93, Issue 5, 2001, Pages 681-686

  Kundu, Namita ^a   Yang, Qingyuan ^a   Dorsey, Russell ^a   Fulton, Amy M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Cyclooxygenase; Metastasis; Prostaglandin

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION;

ANIMALS; BREAST NEOPLASMS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DISEASE MODELS, ANIMAL; FEMALE; INDOMETHACIN; ISOENZYMES; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NITROBENZENES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SULFONAMIDES; TUMOR CELLS, CULTURED;

EID: 0035452412     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1397     Document Type: Article

References (31)

1. Cyclooxygenase-2 inhibitors in tumorigenesis (part I)
2. Cyclooxygenase-2 inhibitors in tumorigenesis (part II)
3. Aspirin use and risk of fatal cancer
4. Epidemiological study of nonsteroidal antiinflammatory drugs and breast cancer
5. Breast cancer and NSAID use: Heterogeneity of effect in a case-control study
6. Nonsteroidal antiinflammatory drugs and breast cancer
7. Relationships of prostaglandin E and natural killer sensitivity to metastatic potential in murine mammary adenocarcinomas
8. Cyclooxygenase-2 gene expression in human breast cancer
9. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer
10. Mammary tumorigenesis in chemical carcinogen-treated mice. VI. Tumor producing capabilities of mammary dysplasias in BALB/cCrgl mice
11. Characterization of metastatic heterogeneity among subpopulations of a single mouse mammary tumor: Heterogeneity in phenotypic stability
12. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors
13. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
14. Effects of indomethacin on the growth of cultured mammary tumors
15. Growth arrest of DMBA-induced mammary carcinogenesis with ibuprofen treatment in female Sprague-Dawley rats
16. Sulfone metabolite of sulindac inhibits mammary carcinogenesis
17. Prostaglandins and breast cancer
18. Survival time after surgery is inversely related to the amounts of prostaglandins extracted from human breast cancers
19. Prostaglandin in human breast cancer: Evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells
20. In vitro prostaglandin production by metastatic breast cancer
21. Prostaglandins in breast cancer: Relationship to disease stage and hormone status
22. Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines
23. Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma
24. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas
25. Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas
26. In vivo effects of indomethacin on the growth of murine mammary tumors
27. Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs
28. Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells
29. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: Growth inhibition by nonsteroidal anti-inflammatory drugs
30. 2 levels in human breast cancer are associated with poor long-term survival
31. Interactions of natural effector cells and prostaglandins in the control of metastasis